- Dosage: Piroxicam 10mg
- Volume: 1ml per Ampoule
- Packaging: Sterile Ampoules for injection, 10 ampoules/tray*1 box
- Shelf Life: 36 months
Package:
Product Description
Piroxicam Injection 1ml:10mg: What the Published Guidance Says
The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.
This page collects the supply-relevant facts for Piroxicam Injection 1ml:10mg — specification, testing, packaging and the registration paperwork that travels with the batch.
- Paracetamol is an antipyretic and analgesic — not an anti-inflammatory The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- A strength-confusion warning that matters commercially The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- The Model List specifies the exact presentations Section 2.1 of the 24th WHO Model List (2025) lists acetylsalicylic acid (suppository 50–150 mg; tablet 100–500 mg), ibuprofen (oral liquid 100 mg/5 mL; tablet 200, 400 and 600 mg) and paracetamol (oral liquid 120 mg/5 mL or 125 mg/5 mL and 250 mg/5 mL; suppository 100 and 250 mg; tablet 250, 325 and 500 mg; dispersible tablet 100 and 250 mg). WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
These points are quoted because they shape how Piroxicam Injection 1ml:10mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Piroxicam Injection 1ml:10mg — Supply Parameters
| Product Name | Piroxicam Injection (Oxicam-Class Non-Steroidal Anti-Inflammatory Drug) |
| Specification | 1mL:10mg (10mg per 1mL ampoule) |
| Dosage Form | Sterile, Nonpyrogenic, Clear Solution for Intramuscular Injection |
| Active Ingredient | Piroxicam |
| Pharmacological Class | Non-Steroidal Anti-Inflammatory Drug (NSAID) / Oxicam Derivative / Analgesic and Anti-Inflammatory Agent |
| Route of Administration | Deep Intramuscular injection only. NOT for intravenous, subcutaneous, or intrathecal administration. |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep ampoules in outer carton until use. |
| Therapeutic group | Analgesics & NSAIDs — Analgesics & NSAIDs |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Lysine Acetylsalicylate Injection 7ml:900mg Ampoule, Diclofenac Sodium Injection 3mL:75mg, Paracetamol Injection 500mg/5mL, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Piroxicam Injection 1ml:10mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Pack size: 1mL clear type I glass ampoule. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoules in outer carton until use..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
This page describes Piroxicam Injection 1ml:10mg as a product of the non-opioid analgesics and NSAIDs named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Frequently Asked Questions
What pack size is available for Piroxicam Injection 1ml:10mg?
The reference pack is 1mL clear type I glass ampoule. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.
What documentation comes with a shipment of Piroxicam Injection 1ml:10mg?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Piroxicam Injection 1ml:10mg support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which strengths of paracetamol oral liquid should we order?
The WHO Model List notes that offering both 120 mg/5 mL and 125 mg/5 mL on one market causes prescribing and dispensing confusion. We recommend selecting one strength per market and will supply accordingly.
Do you supply paracetamol suppositories?
Yes — 150 mg and paediatric strengths. The Model List specifies suppository strengths of 100 mg and 250 mg, and national formularies frequently add intermediates.
Related Analgesics & NSAIDs Products
- Lysine Acetylsalicylate Injection 7ml:900mg Ampoule — 900mg
- Diclofenac Sodium Injection 3mL:75mg — 75mg
- Paracetamol Injection 500mg/5mL — 500mg/5mL
- Ibuprofen Suppository 50mg — 50mg
- Indomethacin Suppository 100mg — 100mg
- Naproxen Suppositories 250mg — 250mg
Browse the full Analgesics & NSAIDs range; all Injectables; the complete product catalogue.
Request a Quotation for Piroxicam Injection 1ml:10mg
Send the specification, pack size, quantity and destination market for Piroxicam Injection 1ml:10mg 1mL and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
